AN2 Therapeutics, Inc., (ANTX) Social Stream
AN2 THERAPEUTICS INC (ANTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ANTX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-12 | 4 | $27 | $22 | $24.5 | $21.53 | 13.79% |
| 2022-11-10 | 4 | $27 | $20 | $23.5 | $21.53 | 9.15% |
| 2022-11-14 | 4 | $25 | $20 | $23.333 | $21.53 | 8.37% |
| 2023-03-30 | 4 | $25 | $24 | $24.5 | $21.53 | 13.79% |
| 2023-05-11 | 3 | $25 | $24 | $24.5 | $21.53 | 13.79% |
| 2023-08-11 | 3 | $24 | $23 | $23.5 | $21.53 | 9.15% |
| 2023-11-10 | 3 | $28 | $23 | $25.5 | $21.53 | 18.44% |
| NA | 3 | $NA | $NA | $NA | $21.53 | NA% |
The Trend in the Analyst Price Target
ANTX's average price target has moved up $2 over the prior 91 days.
ANTX reports an average of 168.84% for its upside potential over the past 32 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-30 | 4 | 25 | 24 | 24.5 | 9.63 | 154.41% |
| 2023-05-12 | 3 | 24 | 23 | 23.5 | 5.09 | 361.69% |
| 2023-08-11 | 3 | 24 | 23 | 23.5 | 8.43 | 178.77% |
| 2023-10-15 | 3 | 27 | 23 | 25.0 | 13.92 | 79.6% |
| 2023-11-10 | 3 | 28 | 23 | 25.5 | 14.31 | 78.2% |
ANTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
ANTX's average broker recommendation rating improved by 0 over the prior 19 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- AN2 THERAPEUTICS INC's number of analysts covering the stock is higher than 117.06% of all US stocks.
- AN2 THERAPEUTICS INC's variance in analysts' estimates is lower than 21.04% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, AN2 THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 208.41% of them.
- In the context of stocks in the small market cap category, AN2 THERAPEUTICS INC's average analyst price target is greater than 629.91% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AN2 THERAPEUTICS INC are BLTE, PEPG, and THRD.
View All Top Stocks by Price Target
Make investment decisions regarding ANTX using the data that counts. Try POWR Ratings for free.